Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1

Journal of Clinical Investigation

Volumn 99, Issue 4, 1997, Pages 752-762

  Sipsas, Nikolaos V ^a   Kalams, Spyros A ^a   Trocha, Alicja ^a   He, Suqin ^a   Blattner, William A ^b   Walker, Bruce D ^a   Johnson, R Paul ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

acquired immunodeficiency syndrome; human immunodeficiency virus infected laboratory workers; human immunodeficiency virus specific cytotoxic T lymphocyte; immune response

Indexed keywords

EPITOPE; VIRUS PROTEIN;

ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; LABORATORY PERSONNEL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0031035445     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119221     Document Type: Article

References (61)

1. McMichael, A.J., and B.D. Walker. 1994. Cytotoxic T lymphocyte epitopes: implications for HIV vaccines. AIDS (Phila.). 8(Suppl. 1):S155-S173.
2. Koup, R.A., J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D.D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
3. Borrow, P., H. Lewicki, B.H. Hahn, G.M. Shaw, and M.B.A. Oldstone. 1994. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
4. Yang, O.O., S. Kalams, M. Rosenzwieg, A. Trocha, M. Koziel, B.D. Walker, and R.P. Johnson. 1996. Efficient lysis of HIV-1 infected cells by cytotoxic T lymphocytes. J. Virol. 70:5799-5806.
5. 4a. Yang, O.O., S.A. Kalams, A. Trocha, H. Cao, A. Luster, R.P. Johnson, and B.D. Walker. 1997. Suppression of HIV-1 replication by CD8+ cells: evidence for HLA class I-restricted trigering of cytolytic and non-cytolytic mechanisms. J. Virol. In press.
6. Harrer, T., E. Harrer, S.A. Kalams, P. Barbosa, A. Trocha, R.P. Johnson, T. Elbeik, M.B. Feinberg, S.P. Buchbinder, and B.D. Walker. 1996. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. J. Immunol. 156:2616-2623.
7. Rinaldo, C., X.-L. Huang, Z. Fan, M. Ding, L. Beltz, L.A.D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838-5842.
8. Klein, M.R., and C.A. van Baalen. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1356-1372.
9. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
10. Rowland-Jones, S., J. Sutton, K. Ariyoski, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
11. Pinto, L.A., J. Sullivan, J.A. Berzofsky, M. Clerici, H.A. Kessler, A.L. Landay, and G.M. Shearer. 1995. Env-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J. Clin. Invest. 96:867-876.
12. Yap, K.L., G.L. Ada, and I.F. McKenzie. 1978. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature (Lond.). 273:238-239.
13. Byrne, J.A., and M.B. Oldstone. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51:682-686.
14. Myers, G., J.A. Berzofsky, B. Korber, R.F. Smith, and G.N. Pavlakis. 1993. Human retroviruses and AIDS 1993: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, NM.
15. Johnson, R.P., A. Trocha, T.M. Buchanan, and B.D. Walker. 1993. Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone. J. Virol. 67: 438-445.
16. Johnson, R.P., A. Trocha, T.M. Buchanan, and B.D. Walker. 1992. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 175:961-971.
17. Reitz, M.S.J., L. Hall, M. Robert-Guroff, J. Lautenberger, B.H. Hahn, G.M. Shaw, L.I. Kong, S.H. Weiss, D. Waters, R.C. Gallo, and W. Blattner. 1994. Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB). AIDS Res. Hum. Retroviruses. 10: 1143-1155.
18. Pincus, S.H., K.G. Messer, P.L. Nara, W.A. Blattner, G. Colclough, and M. Reitz. 1994. Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers. J. Clin. Invest. 93:2505-2513.
19. di Marzo Veroneze, F., M.S. Reitz, G. Gupta, M. Robert-Guroff, C. Boyer-Thompson, A. Louie, R.C. Gallo, and P. Lusso. 1993. Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker. J. Biol. Chem. 268:25894-25901.
20. Pincus, S.H., K.G. Messer, D.H. Schwartz, G.K. Lewis, B.S. Graham, W.A. Blattner, and G. Fisher. 1993. Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp120) in infected laboratory workers and vaccinees. J. Clin. Invest. 91:1987-1996.
21. Wain-Hobson, S., J.-P. Vartanian, M. Henry, N. Chenciner, R. Cheynier, S. Delassus, L. Pedroza Martins, M. Sala, M.-T. Nugeyre, D. Guetard, et al. 1991. LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur. Science (Wash. DC). 252:961-965.
22. Weiss, S.H., J.J. Goedert, S. Gartner, M. Popovic, D. Waters, P. Markham, F. Di Marzo Veroneze, M.H. Gail, E. Barkley, J. Gibbons, F.A. Gill, M. Leuther, G.M. Shaw, R.C. Gallo, and W.A. Blattner. 1988. Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science (Wash. DC). 239:68-71.
23. Centers for Disease Control and Prevention. 1992. 1993 Revised classification system for HIV infection and expanded surveillance of definition for AIDS among adolescents and adults. MMWR (Morb. Mortal Wkly. Rep.). 41: 1-18.
24. Walker, B.D., S. Chakrabarti, B. Moss, T.J. Paradis, T. Flynn, A.G. Durno, R.S. Blumberg, J.C. Kaplan, M.S. Hirsch, and R.T. Schooley. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature (Lond.). 328:345-348.
25. Hammond, S.A., R.P. Johnson, S.A. Kalams, B.D. Walker, M. Takiguchi, J.T. Safrit, R.A. Koup, and R.F. Siliciano. 1995. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CDS8+ CTL. J. Immunol. 154: 6140-6156.
26. Bunce, M., and K. Welsh. 1994. Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): identification of serological and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens. 43:7-17.
27. Earl, P.L., S. Koenig, and B. Moss. 1991. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 65:31-41.
28. Ratner, L., W. Haseltine, R. Patarca, J.K. Livak, B. Starcich, S.F. Josephs, E.R. Doran, J.A. Rafalski, E.A. Whitehorn, K. Baumeister, et al. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (Lond.). 313:277-284.
29. Koup, R.A., J.L. Sullivan, P.H. Levine, D. Brettler, A. Mahr, G. Mazzara, S. McKenzie, and D. Panicali. 1989. Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood 73:1909-1914.
30. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus. Mol. Cell. Biol. 5:3403-3409.
31. Johnson, R.P., S.A. Hammond, A. Trocha, R.F. Siliciano, and B.D. Walker. 1994. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type I (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine. J. Virol. 68:3145-3153.
32. Walker, B.D., C. Flexner, T.J. Paradis, T.C. Fuller, M.S. Hirsch, R.T. Schooley, and B. Moss. 1988. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science (Wash. DC). 240:64-66.
33. Lubaki, M.N., M.A. Egan, R.F. Siliciano, K.J. Weinhold, and R.C. Bollinger. 1994. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. AIDS Res. Hum. Retroviruses. 10:1427-1431.
34. Kalams, S.A., R.P. Johnson, A.K. Trocha, M.J. Dynan, H.S. Ngo, R.T. D'Aquila, J.T. Kurnick, and B.D. Walker. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261-1271.
35. Lefkovits, I., and H. Waldmann. 1979. Limiting dilution analysis of cells of the immune system. Cambridge University Press. Cambridge.
36. Wong, J.T., and R.B. Colvin. 1987. Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. J. Immunol. 139:1369-1374.
37. Johnson, R.P., A. Trocha, L. Yang, G.P. Mazzara, D.L. Panicali, T.M. Buchanan, and B.D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J. Immunol. 147:1512-1521.
38. Walker, B.D., C. Flexner, L.K. Birch, L. Fisher, T.J. Paradis, A. Aldovini, R. Young, B. Moss, and R.T. Schooley. 1989. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 86:9514-9518.
39. Falk, K., O. Rotzsche, M. Tagiguchi, B. Grahovac, V. Gnau, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1994. Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics. 40:238-241.
40. Kubo, R.T., A. Sette, H.M. Grey, E. Appella, K. Sakaguchi, N.-Z. Zhu, D. Arnott, N. Sherman, J. Shabanowitz, H. Michel, et al. 1994. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152:3913-3924.
41. Tsomides, T.J., A. Aldovini, R.P. Johnson, B.D. Walker, R.A. Young, and H.N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 (HIV-1). J. Exp. Med. 180:1283-1293.
42. Shiga, H., T. Shioda, H. Tomiyama, Y. Takamiya, S. Oka, S. Kimura, Y. Yamaguchi, T. Gojoubori, H.-G. Rammensee, K. Miwa, and M. Takiguchi. 1996. Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules. AIDS (Phila.). 10:1075-1083.
43. Harrer, E., T. Harrer, P. Barbosa, M. Feinberg, R.P. Johnson, S. Buchbinder, and B.D. Walker. 1996. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J. Infect. Dis. 173:476-479.
44. Falk, K., O. Rotzschke, B. Grahovac, D. Schendel, S. Stevanovic, G. Jung, and H.G. Rammensee. 1993. Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics. 38:161-162.
45. Kalams, S.A., R.P. Johnson, M.J. Dynan, K.E. Hartman, T. Harrer, E. Harrer, A.K. Trocha, W.A. Blattner, S.P. Buchbinder, and B.D. Walker. 1996. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant. J. Exp. Med. 183:1669-1679.
46. Falk, K., O. Rotzschke, M. Takiguchi, V. Gnau, S. Stevanovic, G. Jung, and H.G. Rammensee. 1995. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behcet's disease. Int. Immunol. 7:223-228.
47. Kawaguchi, G., W.H. Hildebrand, M. Hiraiwa, S. Karaki, T. Nagao, N. Akiyama, S. Uchida, K. Kashiwase, T. Akaza, R.C. Williams, et al. 1992. Two subtypes of HLA-B51 differing by substitution at position 171 of the α2 helix. Immunogenetics. 37:57-63.
48. Sutton, J., S. Rowland-Jones, W. Rosenberg, D. Nixon, F. Gotch, X.M. Gao, N. Murray, A. Spoonas, P. Driscoll, M. Smith et al. 1993. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur. J. Immunol. 23:447-453.
49. Terasaki, P.I. 1980. Histocombatibility testing 1980. Report of the Eighth International Histocombatibility Workshop. Los Angeles, CA. 504-505.
50. Kabat, E., T. Wu, and H. Bilofsky. 1979. National Institutes of Health, Publication No. 80-2008. US Department of Health, Education, and Welfare. Washington, DC.
51. Buseyne, F., M. McChesney, F. Porrot, S. Kovarik, B. Guy, and Y. Riviere. 1993. Gag-specific cytotoxic T lymphocytes from HIV-1 infected individuals: gag epitopes are clustered in three regions of the p24 gag protein. J. Virol. 67:694-702.
52. Clerici, M., D.R. Lucey, R.A. Zajac, R.N. Boswell, H.M. Gebel, H. Takahashi, J.A. Berzofsky, and G.M. Shearer. 1991. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J. Immunol. 146:2214-2219.
53. Culmann, B., E. Gomard, M.P. Kieny, B. Guy, F. Dreyfus, A.G. Saimot, D. Sereni, D. Sicard, and J.P. Levy. 1991. Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein. J. Immunol. 146:1560-1565.
54. Lieberman, J., J.A. Fabry, M.C. Kuo, P. Earl, B. Moss, and P.R. Skolnik. 1992. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in gp160 and reverse transcriptase. J. Immunol. 148:2738-2747.
55. Nixon, D.F., A.R. Townsend, J.G. Elvin, C.R. Rizza, J. Gallwey, and A.J. McMichael. 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature (Lond.). 336:484-487.
56. Phillips, R.E., J.S. Rowland, D.F. Nixon, F.M. Gotch, J.P. Edwards, A.O. Ogunlesi, J.G. Elvin, J.A. Rothbard, C.R. Bangham, C.R. Rizza, and A.J. McMichael. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (Lond.). 354:453-459.
57. Nowak, M., R.M. May, R.E. Phillips, S. Rowland-Jones, D.G. Lalloo, S. McAdam, P. Klenerman, B. Koeppe, K. Sigmund, C.R.M. Bangham, and A.J. McMichael. 1995. Antigneic oscillations and shifting immunodominance in HIV-1 infections. Nature (Lond.). 375:606-611.
58. Gerretti, A.M., M.E.M. Dings, C.A.C.M. van Els, C.A. van Baalen, F.J. Wijnholds, J.C.C. Borleffs, and A.D.M.E. Ostcrhaus. 1996. Human immunodeficiency virus type 1 (HIV-1) and Epstein-Barr virus-specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1-infected persons. J. Infect. Dis. 174:34-45.
59. Ferris, R.L., C. Buck, S.A. Hammond, A.S. Woods, R.J. Cotter, M. Takiguchi, Y. Igarashi, Y. Ichikawa, and R.F. Siliciano. 1996. Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. Implications for the mechanism of processing of viral envelope proteins. J. Immunol. 156:834-840.
60. Kondo, T., H. Uenishi, T. Shimizu, T. Hirama, M. Iwashiro, K. Kuribayashi, H. Tamamura, N. Fujii, R. Fujisawa, M. Miyazawa, and H. Yamagishi. 1995. A single retroviral gag precursor signal peptide recognized by FBL-3 tumor-specific cytotoxic T lymphocytes. J. Virol. 69:6735-6741.
61. Hombach, J., H. Pircher, S. Tonegawa, and R.M. Zinkernagel. 1995. Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein. J. Exp. Med. 182:1615-1619.